Skip to search formSkip to main contentSkip to account menu

L-NDDP

Known as: Liposomal Neodecanoic Acid Platinum Complex, Liposomal-Entrapped Cis-Bis-Neodecanoate-trans-R,R-1,2-Diaminocyclohexane Platinum (II), liposomal-NDDP 
A synthetic liposomal formulation of bis-neodecanoate diaminocyclohexane platinum (NDDP), a third-generation platinum complex analogue of cisplatin… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Historically, malignant pleural mesothelioma patients with potentially resectable disease have been treated with surgery and… 
Review
2007
Review
2007
  • L. Kèlland
  • Expert Opinion on Investigational Drugs
  • 2007
  • Corpus ID: 44788228
The three platinum-containing drugs that have been thus far approved by the FDA – cisplatin, carboplatin and oxaliplatin – have… 
Highly Cited
2006
Highly Cited
2006
Purpose: L-NDDP (AroplatinTM) is a liposomal formulation of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II… 
Highly Cited
2005
Highly Cited
2005
PURPOSE To determine pathologic response rates to liposome-entrapped cis-bisneodecanoato-trans-R,R-1,2-diaminocyclohexane… 
2001
2001
We have developed a visual microwell plate assay for rapid, high-throughput screening for membrane-disrupting molecules such as… 
1997
1997
cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) (NDDP) is a lipophilic non-cross-resistant platinum compound… 
Review
1993
Review
1993
SummaryCisplatin was discovered to have cytotoxic properties in the 1960s, and by the end of the 1970s it had earned a place as… 
1990
Highly Cited
1990
Highly Cited
1990
cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum++ +(II) (NDDP) is a liposome dependent cisplatin analogue since the…